GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Physiomics PYC.L · GBp

Health Care · LSE · 🇬🇧 United Kingdom

Compare

0.43p

+1.19%

Close of 9 Nov 2026, in pence

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Physiomics — daily PYC

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Physiomics on TradingView ↗
Market value
£1.0m
Last close × shares
Volume
676k
Shares, 9 Nov 2026

About Physiomics

Its shares trade on LSE under the ticker PYC.L. It has been listed since 20 December 2004. In the fiscal year to 30 June 2026, it reported revenue of £941,222 and a net loss of £697,034. At that date it held total assets of £788,551 and shareholders' equity of £523,977.

Physiomics Plc engages in the provision of outsourced systems and computational biology services to pharmaceutical companies. The company is headquartered in Oxford, Oxfordshire. The company went IPO on 2004-12-20. The firm is focused on the development of Virtual Tumour Clinical, to directly predict optimal regimens for human clinical trials; Cardiac tox prediction service, to predict unwanted toxic side effects of drug candidates in the drug discovery process, and Drug combinations database, for researchers and clinicians to access literature data on pre-clinical and clinical regimens and their effects. Its services include Target Validation, Mechanism of Action Studies, Lead Selection, Clinical Pharmacokinetic/Pharmacodynamics (PK/PD), EASYAP/Cardiac Toxicity Service, Virtual Tumour Preclinical and Virtual Tumour Clinical. The company offers a services and technology for predicting cardiac toxicity. The company also focuses on offering offer Model Based Drug Development (MBDD) services, which include Population PKPD analysis of clinical data and Back-translational analysis.

Figures and description from our data supplier, not checked against the company's own report.

More about Physiomics →

Latest on Physiomics

Our reporting

We have not reported on Physiomics yet.

Next results

11 Mar 2027

Due on 11 Mar 2027.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Physiomics's ticker?

Physiomics trades as PYC.L on LSE, under ISIN GB00BDR6W943.

What was Physiomics's last closing price?

0.43p on 9 Nov 2026. The figure is in GBp and is never converted.

When does Physiomics next report results?

Results are expected on 11 Mar 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.